Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease - Test2 - elhamkhani - TriplyDB

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

http://www.wikidata.org/entity/Q33727211

about

Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment Crohn's disease and skin Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Use of thiopurines in inflammatory bowel disease Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists Review article: anti-adhesion therapies for inflammatory bowel disease Preventive health measures in inflammatory bowel disease Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.Use of thiopurines in inflammatory bowel disease: Safety issues.Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Systemic glucocorticoid use and early-onset basal cell carcinoma Adverse events in IBD: to stop or continue immune suppressant and biologic treatment Preparing for biologic or immunosuppressant therapy.Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.Inflammatory bowel disease cause-specific mortality: a primer for clinicians Do inflammatory bowel disease therapies cause cancer?Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer Nonmelanoma skin cancer in inflammatory bowel disease: a review The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model.Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation Roles of the immune system in skin cancer.Cancer and immunomodulators in inflammatory bowel diseases.Pleomorphic malignant histiocytoma: a rare skin cancer in a patient on azathioprine for ulcerative colitis.Increased risk of pneumonia among patients with inflammatory bowel disease.Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.Thiopurines in inflammatory bowel disease revisited Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda.Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.Quality improvement in inflammatory bowel disease.Cancer risk in immune-mediated inflammatory diseases (IMID).Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases Preventative care for patients with inflammatory bowel disease in the Veterans Health Administration.Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.Thiopurine therapy in inflammatory bowel disease.

P2860

Q26745456-50801150-06D7-4A49-83A7-E0D50D22331E Q26752869-6EC90A70-BE32-4E27-A81B-F1B0CA83150E Q26777400-E995AD32-B6AA-4461-8B48-7113219422A8 Q26801119-E3AAFC6F-9467-4402-B181-04700607759F Q26822029-F0AFB0ED-11F9-4B8A-BDB2-7627D1373E2A Q26824662-1D2A6634-5CF9-4692-8CF3-37E98FE5AD4B Q26866940-B42EA9A9-1D95-4F9B-AB32-75DFDF39E691 Q26999078-3ABAA3BB-388D-4952-8A13-AA46E08BF316 Q26999705-91674C8C-96ED-4AB9-A5F4-11C37DBFE7C2 Q28078112-909786A4-D552-4564-AC12-2D1D3F6C8C6C Q28079644-86289849-A076-4794-B09E-17ACBF9F0234 Q31113830-964BC7D7-C790-480B-9392-A89DAD7CA2EF Q33621267-D0573C96-5037-46D2-9F22-6398BD5FB07C Q33786255-939650C7-4845-44B9-BDE4-C888823B5B3F Q33819478-F3190B5E-F3E6-4BB8-AA37-CF68DBCAA789 Q33992197-A48136B7-8D63-4837-9075-196252B8B4DE Q34073191-7C00B049-62A8-434D-9791-715D7E01F9A1 Q34251371-CA14AFD1-ED9D-4940-B2EE-FFAF53A49D2C Q34354492-31494198-7881-4630-886A-E7917A60FB2D Q34570452-AA4A0641-2E2A-46B4-9A59-02BF529C3F90 Q34613890-546431AB-1370-4F43-9051-794663F19BA9 Q34637366-E432F3D4-AD7D-4BC3-AD65-56CABE681682 Q34975612-118917C2-978F-4A55-B267-A46E8A02AB46 Q35072606-81588910-78F1-4686-A646-7A76488E524F Q35183184-B43CE693-65AF-4638-A3C2-96980DFA1F95 Q35403714-FD552533-ED7E-46C7-AC16-60E9A0D9CE0F Q35534959-FFD32299-EDCA-4AAA-9600-8722C27206CC Q36081139-A83CC7D8-70B1-416F-AAC7-8894832A2D3C Q36219145-C4BA48B2-762B-4FAF-B6A1-E698A9A2557E Q36677345-552B4B9D-053A-4C2B-B871-C6197DBF03B9 Q36715034-C7C79DE5-BC7B-43DE-BB7E-2043614F561D Q37087227-E8A879A7-8737-401C-8E4E-5BCFCCDC544E Q37087479-ED41B22D-C7FF-47A1-8AFF-117468858E9D Q37088512-7D99DD1A-212D-4005-B53D-BBAF350CC885 Q37153407-763772DE-E6D4-48FE-85C3-7E87B0677629 Q37186231-390D4321-B55D-4AF0-90D5-84C448791A25 Q37327937-19C04DB7-739C-4C97-B070-A4A0833028A9 Q37429242-8F689DB4-901B-45D1-AE70-303AE93EAD0D Q37456737-4F5A1C58-5D75-426E-B83C-E0B041C48F42 Q37798819-3499B53F-DF9A-4C46-AA4F-14BFF2F65DDF

P2860

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

http://www.wikidata.org/entity/Q33727211

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

@ast

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

@en

type

label

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

@ast

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

@en

prefLabel

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

@ast

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

@en

P1433

Q33727211-6420B68D-A87D-4CF7-86E5-022502BF92CE

P1476

Q33727211-96E3F360-B718-4F4A-BFF8-BB653BADD0ED

P2093

Q33727211-12680906-A1DB-4917-A970-F6D07EE84E8F

Q33727211-1BD601ED-C11F-494E-989B-873AAA295B05

Q33727211-25A6F385-E0F8-476A-99E2-08F90D5F08FE

Q33727211-57B239D5-5974-49C3-A60B-71DB34E78875

Q33727211-ED175B9C-326B-4DBB-A11E-EB6598138594

P2860

Q33727211-17DAF54C-181E-4EB5-A4DD-03C89E0C409A

Q33727211-22E91074-2D07-4075-A38F-EA298FC4211F

Q33727211-233F9E01-E984-4529-95B6-2E980813D384

Q33727211-4AF3F149-09D0-4620-AF4C-9A3447D752D5

Q33727211-51A06A89-1B6B-465E-AD9F-78BD6B6BABF1

Q33727211-58FCE788-9D9D-431F-AB45-FE0B66DB3191

Q33727211-6D279858-CAA1-4E36-9381-B6CFD7F6ECBC

Q33727211-7B630E38-723D-45FC-9921-6B73AA376FDE

Q33727211-7F63D385-B535-46EF-BD54-CBB13226BEC6

Q33727211-84E1D71C-77C4-46CD-BFDE-78090306D93C

P304

Q33727211-5AB8F186-7804-4603-841F-1E0CD2AF08CA

P31

Q33727211-2C246B67-66BD-4C8A-BAA1-4133DCDEAD86

P356

Q33727211-7DEA0828-561B-4DF2-981D-6E9229727328

P407

Q33727211-68D5FF14-9A5F-413D-8B6E-3605AFB3448F

P433

Q33727211-B3E974F2-98DD-4B97-88CD-7465A633E75A

P478

Q33727211-9695A8C7-FCE7-4FC4-A91C-7C8AD7589CE9

P50

Q33727211-3C6A846D-FAE1-4869-90DA-B31301CF81BF

P577

Q33727211-757E7876-2E90-4E90-9FC6-B3FC5125FF45

P5875

Q33727211-AB4EAB73-83FC-4204-AE13-9B51CF87BE01

P698

Q33727211-14183809-E8A1-4047-9A4C-D041F3DB35B0

P921

Q33727211-9EFBC481-8D09-4FFE-93CC-2A62517A3774

Q33727211-BA0B960E-0FB4-4CE4-9572-3F576B626129

P932

Q33727211-F8CFFA68-848A-418A-BBCB-10ED8F9BE6F7

P356

J.CGH.2009.11.024

P1433

Clinical Gastroenterology and Hepatology

P1476

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

@en

P2093

Carol Q Porter

http://www.w3.org/2001/XMLSchema#string

Clare A Pipkin

http://www.w3.org/2001/XMLSchema#string

Hans H Herfarth

http://www.w3.org/2001/XMLSchema#string

Michael D Kappelman

http://www.w3.org/2001/XMLSchema#string

Millie D Long

http://www.w3.org/2001/XMLSchema#string

P2860

Azathioprine and UVA light generate mutagenic oxidative DNA damage

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Suboptimal rates of cervical testing among women with inflammatory bowel disease

Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management.

Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.

Skin cancers after organ transplantation.

Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.

Common skin cancers and their precursors.

Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.

Cancer in patients with ulcerative colitis.

P304

268-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2009.11.024

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Robert S Sandler

P577

2010-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40683791

http://www.w3.org/2001/XMLSchema#string

P698

20005977

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

2838486

http://www.w3.org/2001/XMLSchema#string